{"id":172430,"date":"2023-09-20T10:22:21","date_gmt":"2023-09-20T15:22:21","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2023\/09\/pioneering-cbd-for-epilepsy-treatment-and-prevention"},"modified":"2023-09-20T10:22:21","modified_gmt":"2023-09-20T15:22:21","slug":"pioneering-cbd-for-epilepsy-treatment-and-prevention","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2023\/09\/pioneering-cbd-for-epilepsy-treatment-and-prevention","title":{"rendered":"Pioneering CBD For Epilepsy Treatment And Prevention"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/pioneering-cbd-for-epilepsy-treatment-and-prevention2.jpg\"><\/a><\/p>\n<p>A Texas A&amp;M University professor and a team of pharmacology researchers are spearheading advances in the use of medical cannabinoids for epilepsy and seizure disorders.<\/p>\n<p>A team led by Dr. D. Samba Reddy, a Regents Professor in the Department of Neuroscience and Experimental Therapeutics at the Texas A&amp;M University School of Medicine, has made progress in determining efficacy, safety and new applications of cannabinoid therapeutics. Reddy\u2019s work establishes a foundation for tailored and effective epilepsy treatments, offering hope to those facing its challenges.<\/p>\n<p>The team\u2019s research on epilepsy has resulted in the publication of five key papers featured in the May 2023 issue of the journal Experimental Neurology.<\/p>\n<p>\u201cThe medical cannabis research originated from the patient families and advocates in Colorado who have witnessed the positive effects of medical cannabis products,\u201d said Reddy, who is a founding director of the Texas A&amp;M Health Institute of Pharmacology and Neurotherapeutics.<\/p>\n<hr>\n<p>Pharmacology research team reveals breakthrough findings on cannabinoid therapy for preventing epilepsy and refractory seizure disorders.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A Texas A&amp;M University professor and a team of pharmacology researchers are spearheading advances in the use of medical cannabinoids for epilepsy and seizure disorders. A team led by Dr. D. Samba Reddy, a Regents Professor in the Department of Neuroscience and Experimental Therapeutics at the Texas A&amp;M University School of Medicine, has made progress [\u2026]<\/p>\n","protected":false},"author":534,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11,1495],"tags":[],"class_list":["post-172430","post","type-post","status-publish","format-standard","hentry","category-biotech-medical","category-health"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/172430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/534"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=172430"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/172430\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=172430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=172430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=172430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}